phase i trang 5 tải miễn phí từ tailieunhanh

"phase i" trang 5 - tải miễn phí từ tailieunhanh

Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): Study protocol of a phase I/II clinical trial

13 78 1

INTRAGO: Intraoperative radiotherapy in glioblastoma multiforme – a Phase I/II dose escalation study

9 31 1

Dose escalating study of cetuximab and 5-FU/ folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer

8 32 1

A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers

6 27 1

Transarterial infusion chemotherapy with cisplatin plus S-1 for hepatocellular carcinoma treatment: A phase I trial

6 45 1

$Concurrent chemoradiotherapy with tomotherapy in locally advanced non-small cell lung cancer: A phase i, docetaxel dose-escalation study, with hypofractionated radiation regimen$

Concurrent chemoradiotherapy with tomotherapy in locally advanced non-small cell lung cancer: A phase i, docetaxel dose-escalation study, with hypofractionated radiation regimen

7 59 1

$Topical cutaneous application of carbon dioxide via a hydrogel for improved fracture repair: Results of phase I clinical safety trial$

Topical cutaneous application of carbon dioxide via a hydrogel for improved fracture repair: Results of phase I clinical safety trial

14 28 1

Ablative radiation therapy to restrain everything safely treatable (ARREST): Study protocol for a phase I trial treating polymetastatic cancer with stereotactic radiotherapy

10 22 1

Transient paradoxical bronchospasm associated with inhalation of the LAMA AZD9164: Analysis of two Phase I, randomised, double-blind, placebo-controlled studies

13 35 1

A phase I/II clinical trial on the efficacy and safety of NKT cells combined with gefitinib for advanced EGFR-mutated non-small-cell lung cancer

8 28 1

Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: An open-label, multi-center phase I study

10 41 3

Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: A phase I study

10 26 1

Safety and efficacy of MIKE-1 in patients with advanced pancreatic cancer: A study protocol for an open-label phase I/ II investigator-initiated clinical trial based on a drug repositioning approach that reprograms the tumour stroma

11 24 1

$Single fraction ablative preoperative radiation treatment for early-stage breast cancer: The CRYSTAL study – a phase I/II clinical trial protocol$

Single fraction ablative preoperative radiation treatment for early-stage breast cancer: The CRYSTAL study – a phase I/II clinical trial protocol

12 25 1

Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: A phase I trial

10 21 2

Triple modal treatment comprising with proton beam radiation, hyperthermia, and gemcitabine/nab-paclitaxel for locally advanced pancreatic cancer: A phase I/II study protocol (TT-LAP trial)

9 1 1

Involved site radiation therapy in stage I-III nasopharyngeal carcinoma with limited lymph node burden (ISRT-NPC) or elective region irradiation: A study protocol for a multicenter non-inferiority randomized controlled phase III clinical trial

11 1 1

Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasound

10 1 1

$Hypofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: Study protocol of the phase I HYDRA trial$

Hypofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: Study protocol of the phase I HYDRA trial

8 7 1

Afatinib plus osimertinib in the treatment of osimertinib-resistant non-small cell lung carcinoma: A phase I clinical trial

9 1 1